WuXi AppTec Zukünftiges Wachstum
Future Kriterienprüfungen 1/6
WuXi AppTec is forecast to grow earnings and revenue by 15.5% and 9.7% per annum respectively. EPS is expected to grow by 16% per annum. Return on equity is forecast to be 15.6% in 3 years.
Wichtige Informationen
15.6%
Wachstumsrate der Gewinne
16.1%
EPS-Wachstumsrate
Life Sciences Gewinnwachstum | 34.7% |
Wachstumsrate der Einnahmen | 9.8% |
Zukünftige Eigenkapitalrendite | 15.6% |
Analystenabdeckung | Good |
Zuletzt aktualisiert | 30 Oct 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
Is WuXi AppTec Co., Ltd. (SHSE:603259) Potentially Undervalued?
Oct 22WuXi AppTec Co., Ltd. (SHSE:603259) Stock Catapults 34% Though Its Price And Business Still Lag The Market
Oct 01Benign Growth For WuXi AppTec Co., Ltd. (SHSE:603259) Underpins Its Share Price
Jul 30These 4 Measures Indicate That WuXi AppTec (SHSE:603259) Is Using Debt Reasonably Well
Jul 12WuXi AppTec (SHSE:603259) Has Announced That It Will Be Increasing Its Dividend To CN¥0.9897
Jun 23We Think Some Shareholders May Hesitate To Increase WuXi AppTec Co., Ltd.'s (SHSE:603259) CEO Compensation
Jun 05WuXi AppTec (SHSE:603259) Has A Pretty Healthy Balance Sheet
Apr 09WuXi AppTec Co., Ltd. (SHSE:603259) Analysts Just Slashed This Year's Estimates
Mar 23Benign Growth For WuXi AppTec Co., Ltd. (SHSE:603259) Underpins Its Share Price
Mar 01Gewinn- und Umsatzwachstumsprognosen
Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
---|---|---|---|---|---|
12/31/2026 | 48,601 | 12,048 | 9,362 | 14,996 | 20 |
12/31/2025 | 43,360 | 10,679 | 7,944 | 13,082 | 23 |
12/31/2024 | 39,500 | 9,596 | 6,278 | 12,452 | 22 |
9/30/2024 | 38,501 | 8,063 | 7,091 | 11,449 | N/A |
6/30/2024 | 38,710 | 8,533 | 8,143 | 12,755 | N/A |
3/31/2024 | 39,359 | 9,381 | 7,559 | 12,617 | N/A |
12/31/2023 | 40,341 | 9,607 | 7,870 | 13,387 | N/A |
9/30/2023 | 40,502 | 9,512 | 6,354 | 13,223 | N/A |
6/30/2023 | 40,470 | 9,491 | 4,256 | 12,218 | N/A |
3/31/2023 | 39,844 | 9,339 | 4,118 | 13,146 | N/A |
12/31/2022 | 39,355 | 8,814 | 650 | 10,616 | N/A |
9/30/2022 | 34,776 | 8,913 | 266 | 9,118 | N/A |
6/30/2022 | 30,122 | 7,058 | -2,178 | 6,442 | N/A |
3/31/2022 | 26,426 | 5,240 | -3,653 | 4,418 | N/A |
12/31/2021 | 22,902 | 5,097 | -2,347 | 4,589 | N/A |
9/30/2021 | 21,242 | 4,154 | -1,209 | 4,733 | N/A |
6/30/2021 | 19,841 | 3,918 | 3 | 4,681 | N/A |
3/31/2021 | 18,298 | 4,157 | -172 | 3,545 | N/A |
12/31/2020 | 16,535 | 2,960 | 943 | 3,974 | N/A |
9/30/2020 | 15,408 | 2,454 | 944 | 3,565 | N/A |
6/30/2020 | 14,209 | 2,512 | 879 | 3,373 | N/A |
3/31/2020 | 13,290 | 1,768 | 1,452 | 3,823 | N/A |
12/31/2019 | 12,872 | 1,851 | 384 | 2,916 | N/A |
9/30/2019 | 11,971 | 2,097 | -305 | 2,496 | N/A |
6/30/2019 | 11,099 | 2,045 | -409 | 2,121 | N/A |
3/31/2019 | 10,241 | 2,356 | -536 | 1,862 | N/A |
12/31/2018 | 9,614 | 2,261 | -608 | 1,640 | N/A |
9/30/2018 | 9,009 | 2,092 | -73 | 1,589 | N/A |
6/30/2018 | 8,509 | 1,757 | N/A | 1,718 | N/A |
3/31/2018 | 8,139 | 1,181 | N/A | 1,654 | N/A |
12/31/2017 | 7,765 | 1,227 | N/A | 1,794 | N/A |
12/31/2016 | 6,116 | 975 | N/A | 1,757 | N/A |
12/31/2015 | 4,883 | 349 | N/A | 739 | N/A |
12/31/2014 | 4,140 | 462 | N/A | 713 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: 603259's forecast earnings growth (15.5% per year) is above the savings rate (2.9%).
Ertrag vs. Markt: 603259's earnings (15.5% per year) are forecast to grow slower than the CN market (25.8% per year).
Hohe Wachstumserträge: 603259's earnings are forecast to grow, but not significantly.
Einnahmen vs. Markt: 603259's revenue (9.7% per year) is forecast to grow slower than the CN market (14% per year).
Hohe Wachstumseinnahmen: 603259's revenue (9.7% per year) is forecast to grow slower than 20% per year.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: 603259's Return on Equity is forecast to be low in 3 years time (15.6%).